The expression of interleukin 4 (IL-4) receptors on resting T and B lymphocytes was enhanced 4-to 8-fold by IL-4 stimulation of these cells. Other agents such as lipopolysaccharide and anti-IgM for B cells and concanavalin A for T cells also caused increased IL-4 receptor expression, although to a somewhat smaller degree than IL-4. Using a newly developed flow cytometric analysis based on the binding of biotinylated IL-4 and phycoerythrin-streptavidin, it was observed that receptor up-regulation in a T-cell population treated with IL-4 was a feature of the majority of the T cells. Analysis of IL-4 by cross-linkage of '2MI-labeled IL-4 to IL-4 receptor with disuccinimidyl suberate indicated that the IL-4-IL-4 receptor complex was the same size in the resting and up-regulated cells, implying that the same receptor species found in resting cells was up-regulated in response to IL-4.
Recent studies have shown that lymphocyte proliferative and differentiative responses to antigenic stimulation are controlled by endogenous hormone-like substances designated lymphokines. Among these, interleukin 4 (IL-4)/B-cell stimulatory factor 1 is particularly notable in its range of biologic activities (1) . IL-4 has been purified to homogeneity (2, 3) and cDNA clones for IL-4 (4-6) have been obtained. An anti-IL-4 monoclonal antibody that inhibits its biologic activities has been generated (7) . Recently, high-afflinity IL-4 receptors have been demonstrated on mouse and human cells of various lineages by using 12511 or 35S-labeled IL-4 (8-13).
High-affinity receptors are expressed on normal resting B cells and T cells.
We have reported that stimulation of B cells with lipopolysaccharide (LPS) or with anti-IgM and of T cells with concanavalin A (Con A) increased the receptor expression (8) . In this study, we demonstrate that resting B cells and T cells increase receptor number upon stimulation with IL-4 alone.
MATERIALS AND METHODS
Animals, Culture Medium, and Cell Preparation. BALB/c, C3H/HeN, and DBA/2 female mice, [8] [9] [10] [11] [12] weeks old, were obtained from the Frederick Cancer Research Facility (Frederick, MD). Cells were cultured in RPMI 1640 medium (Biofluids, Rockville, MD) supplemented with 10% fetal bovine serum (Biofluids), L-glutamine (2 mM), and gentamicin (50 ,tg/ml). Purified B cells were prepared from spleen (14) , and purified T cells were prepared from mesenteric lymph nodes as described (15) .
Cytokines. Purified IL-4 was prepared as described from supernatant (Sn) fluids of cells of the thymoma line EL-4 that had been activated with phorbol 12-myristate 13-acetate (PMA) (3) and from the culture Sn of Sf9 cells infected with a recombinant IL-4 baculovirus (C. Watson, J.O., and W.E.P., unpublished data). Recombinant mouse IL-4 from a yeast expression system was kindly provided by Immunex (Seattle). Biologic unitages of chemically purified IL-4 and of recombinant IL-4 were determined by both an anti-IgM costimulation assay, using purified B cells, and a T-cell proliferation assay, using the IL-4-responsive CT.4R cell line as described elsewhere (J. Hu-Li, J.O., C. Watson, and W.E.P., unpublished data). One unit is equal to 3-5 pg (2) of purified IL-4. Recombinant human interleukin 2 (IL-2) was kindly provided by Cetus (Emeryville, CA).
Chemicals. PMA and avidin-Sepharose 4B were purchased from Sigma. A23187 was from Calbiochem. LPS and Con A were obtained from Difco. Goat anti-IgM antibody was prepared and purified in our laboratory. The monoclonal rat anti-mouse IgM antibody Bet-2 (16) was used as a 1:10 dilution of a 10-fold concentrated Sn of hybridoma cells. Disuccinimidyl suberate and N-hydroxysuccinimide D-biotin were from Pierce. Streptavidin-phycoerythrin (PE) conjugate was obtained from Becton Dickinson.
'2-5-Labeled IL-4 ('2-5-IL-4) Binding Assay. Purified IL-4 was '251-labeled as described (8) . Equilibrium constants and receptor numbers were determined by Scatchard analysis. In experiments in which only receptor number was determined, cells were incubated with a single concentration (124 pM) of 1251-IL-4 sufficient to bind to '80% of receptors. More than 100-fold excess of nonradioactive IL-4 was added to some reaction mixtures as an inhibitor. Specifically bound IL-4 was determined from the difference between bound radioactivity in the absence or presence of inhibitor.
Biotinylation. Purified baculovirus-derived recombinant IL-4 (350 ug) and N-hydroxysuccinimide D-biotin (500 ,ug) reacted in 0.5 ml of sodium bicarbonate (0.1 M; pH 7.8) for 2 hr at room temperature. The protein was extensively dialyzed against phosphate-buffered saline (PBS). The biological activity of biotinylated recombinant IL-4 was measured by the [3H]thymidine uptake assay using CT.4R cells.
All of the biological activity of the biotinylated IL-4 preparation was removed by passage over an avidin-Sepharose 4B column, implying that all biologically active IL-4 had been biotinylated.
Flow (8, 9) . These same cell populations showed somewhat greater increases in numbers of IL-4 receptors in response to IL-4 itself. Both purified T-cell-derived IL-4 and recombinant IL-4 caused increases in numbers of IL-4 receptors on B and T cells (Table 1) Increased receptor number in T cells could be detected within 6-12 hr of initiation of culture with IL-4 and plateaued between 18 and 24 hr (Fig. 2B) . B cells showed similar time dependency (data not shown). Maximal up-regulation was To optimize the technique, we used a cell line (CT.4R) with a large number of IL-4 receptors (-15,000 per cell) and added various amounts of biotinylated IL-4 to cells that had been preincubated with no IL-4 or with excess nonbiotinylated IL-4. Table 2 shows that specific (i.e., IL-4 inhibitable) binding occurred with all concentrations of biotinylated IL-4 used. For future work, we chose a concentration of biotinylated IL-4 (6.5 x 10 1-M) that gave specific binding 60-75% of maximal but that had a relatively low nonspecific binding. The CT.4R cells (5 x 105) were incubated with medium or purified baculovirus-derived recombinant IL-4 (-6 x 10-6 M) for 30 min at 40C. Biotinylated IL-4, at the final concentration indicated, was added and incubation continued for an additional 30 min. Cells were washed twice and PE-streptavidin (5 CT.4R cells was 11.4 fluorescence units (Fig. 3) . The ratio of receptor number (6.5) and of AMFI (5.0) was sufficiently similar to indicate that the fluorescence binding approach could give useful information about the relative number of receptors on different cell populations and on the distribution of receptors in a cell population.
We used this method to determine whether IL-4 upregulation of IL-4 receptor expression on normal T cells was a property of the majority of the T cells or of small subpopulations. Resting lymph node T cells were cultured with medium or recombinant IL-4 (100 units/ml) for 22 hr and the specific binding of biotinylated IL-4 was measured. T cells cultured in medium only had barely detectable IL-4-inhibitable binding (AMFI = 0.8) (Fig. 4) , while the T-cell population cultured with IL-4 expressed a AMFI of 41. This verifies by another technique that IL-4 enhances the expression of the IL-4 receptor on resting T cells. In addition, the shape of the fluorescence histograms indicates that the great majority of the cells cultured in IL-4 express more IL-4 receptors than do cells cultured in medium. Since IL-4 does not cause proliferation of resting T cells and since the viability of cells cultured in IL-4 for 24 hr is excellent (16), we conclude that the IL-4-induced up-regulation of IL-4 receptors is a process that occurs in virtually all lymph node T cells.
DISCUSSION
In this study, we have confirmed the previous findings of IL-4 receptor up-regulation by mitogens reported by our group as well as others (8, 9) and demonstrated that IL-4 is a potent inducer of IL-4 receptors on both B and T lymphocytes. The up-regulated IL-4 receptors on stimulated lymphocytes appeared to be identical to those expressed on unstimulated lymphocytes in terms of the size of the molecular complex formed by cross-linking I251-IL-4 to the IL-4 receptor on cell surfaces. Although we have not determined the mechanism of receptor up-regulation, the fact that 6 hr is required before a substantial increase in receptor number is observed suggests that new receptor synthesis rather than redistribution of receptors is necessary. Furthermore, we observed that cycloheximide blocked receptor up-regulation (J.O., unpublished observation), further supporting the idea that new receptor synthesis is required for IL-4-induced increase in receptor number. recombinant IL-4 and streptavidin-PE, demonstrating that IL-4-mediated up-regulation of IL-4 receptors is a property of the great majority of lymph node T cells. Obviously, this technique could be used in multiparameter analysis to characterize relative degrees of receptor expression in various populations. Indeed, a similar system has been developed for the flow cytometric detection of the IL-6 receptor (17).
The up-regulation ofa growth factor receptor by its specific ligand has been reported in the IL-2/IL-2 receptor system. IL-2 binding to IL-2 receptors on normal T lymphocytes and T-cell clones causes an increase in the expression of the p55 chain of the IL-2 receptor by increasing transcription with a consequent increase in numbers of high-affinity IL-2 receptors.
Although both the IL-4 receptor and the p55 chain of the IL-2 receptor increase in expression as a result of exposure to their ligands, the control of these receptors is not identical.
Thus, IL-2 failed to cause increased IL-4 receptor expression on restipg T cells in contrast to the striking effect that IL-4 exerts on IL-4 receptor expression in these cells. IL-4 by itself fails to cause a detectable increase in p55 expression on resting T cells, although in combination with PMA, IL-4 does T-Cells Cultured in Medium cause some up-regulation of p55 (18) . Furthermore, the relative degree of up-regulation of the two receptors appears different. IL-4 receptors are detectable on resting T cells and increase by -5-fold in response to IL-4. By contrast, p55 expression is usually undetectable on resting T cells and stimulated cells show increases of great magnitude (19) . Of course, it may be more relevant to compare regulation of IL-4 receptor expression to that of the p70 chain of the IL-2 receptor. p70 appears to mediate the signaling function of the receptor, but little is known about the regulation of the level of its expression; by contrast, p55 by itself appears not to cause cellular activation in response to IL-2.
Recently, a T-cell line (CT.4R) that can grow in IL-4 alone or in IL-2 alone was derived from a subline of the IL-2-dependent T-cell line CTLL (J. Hu-Li, J.O., C. Watson, and W.E.P., unpublished data). CT CT.4R cells are much more sensitive to IL-4 than are CT.EV cells; indeed, the latter cells cannot be propagated in IL-4 alone. These results suggest the existence of distinct regulatory mechanisms of growth factor receptor expression by their specific ligands. Furthermore, the fact that the same cell line displays independent ligand-mediated regulation of two growth factor receptors suggests that the signaling mechanisms used by these receptors are not identical.
